Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy

Journal of the American Society of Nephrology

Volumn 16, Issue 5, 2005, Pages 1384-1391

  Chen, Jian Kang ^a   Chen, Jianchun ^a   Neilson, Eric G ^a   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN S6; RAPAMYCIN; CARRIER PROTEIN; EIF4EBP1 PROTEIN, MOUSE; IMMUNOSUPPRESSIVE AGENT; PHOSPHOPROTEIN; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; IMMUNOBLOTTING; KIDNEY COMPENSATORY HYPERTROPHY; MALE; MONOSOME; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; POLYSOME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RIBOSOME; RIBOSOME SUBUNIT; RNA SYNTHESIS; SIGNAL TRANSDUCTION; UNINEPHRECTOMY; ADAPTATION; ANIMAL; DBA MOUSE; DRUG EFFECT; HYPERTROPHY; KIDNEY; METABOLISM; NEPHRECTOMY; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARRIER PROTEINS; HYPERTROPHY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MICE; MICE, INBRED DBA; NEPHRECTOMY; PHOSPHOPROTEINS; PHOSPHORYLATION; POLYRIBOSOMES; PROTEIN KINASES; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 23944491271     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004100894     Document Type: Article

References (50)

1. Fine LG, Norman J: Cellular events in renal hypertrophy. Annu Rev Physiol 51: 19-32, 1989
2. Preisig PA: Renal hypertrophy and hyperplasia. In: The Kidney, Vol. 1, 3rd ed, edited by Selden DW, Giebisch G, Philadelphia, Lippincott Williams & Wilkins, 2000, pp 727-748
3. Brenner BM: Remission of renal disease: Recounting the challenge, acquiring the goal. J Clin Invest 110: 1753-1758, 2002
4. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 35: 654-660, 1989
5. Fogo A, Ichikawa I: Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 17: 666-669, 1991
6. Hostetter TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 57: 263-278, 1995
7. Wolf G, Mueller E, Stahl RA, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92: 1366-1372, 1993
8. Franch HA, Shay JW, Alpern RJ, Preisig PA: Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy. J Cell Biol 129: 245-254, 1995
9. Liu B, Preisig P: TGF-beta1-mediated hypertrophy involves inhibiting pRB phosphorylation by blocking activation of cyclin E kinase. Am J Physiol 277: F186-F194, 1999
10. Monkawa T, Hiromura K, Wolf G, Shankland SJ: The hypertrophic effect of transforming growth factor-beta is reduced in the absence of cyclin-dependent kinase inhibitors p21 and p27. J Am Soc Nephrol 13: 1172-1178, 2002
11. Wolf G, Jablonski K, Schroeder R, Reinking R, Shankland SJ, Stahl RA: Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1. Kidney Int 64: 71-81, 2003
12. Liu B, Preisig PA: Compensatory renal hypertrophy is mediated by a cell cycle-dependent mechanism. Kidney Int 62: 1650-1658, 2002
13. Schmelzle T, Hall MN: TOR, a central controller of cell growth. Cell 103: 253-262, 2000
14. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J: Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16: 1472-1487, 2002
15. Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC Jr, Abraham RT: Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277: 99-101, 1997
16. Gingras AC, Raught B, Sonenberg N: mTOR signaling to translation. Curr Top Microbiol Immunol 279: 169-197, 2004
17. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC: Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 17: 6649-6659, 1998
18. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G: Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 16: 3693-3704, 1997
19. Meyuhas O: Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 267: 6321-6330, 2000
20. Chen JK, Falck JR, Reddy KM, Capdevila J, Harris RC: Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J Biol Chem 273: 29254-29261, 1998
21. Rao J, Otto WR: Fluorimetric DNA assay for cell growth estimation. Anal Biochem 207: 186-192, 1992
22. Esposito C, He CJ, Striker GE, Zalups RK, Striker LJ: Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol 154: 891-897, 1999
23. Shechter P, Shi JD, Rabkin R: Renal tubular cell protein breakdown in uninephrectomized and ammonium chloride-loaded rats. J Am Soc Nephrol 5: 1201-1207, 1994
24. Rabkin R, Shechter P, Shi JD, Boner G: Protein turnover in the hypertrophying kidney. Miner Electrolyte Metab 22: 153-156, 1996
25. Harris RC: Regulation of S6 kinase activity in renal proximal tubule. Am J Physiol 263: F127-F134, 1992
26. Alberti P, Bardella L, Comolli R: Ribosomal protein S6 kinase is activated after folk acid injury and epidermal growth factor administration but not after unilateral nephrectomy in the rat kidney. Nephron 60: 330-335, 1992
27. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL: A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756-758, 1994
28. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL: Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 377: 441-446, 1995
29. Park IH, Bachmann R, Shirazi H, Chen J: Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J Biol Chem 277: 31423-31429, 2002
30. Proud CG: Control of the translational machinery in mammalian cells. Eur J Biochem 269: 5337, 2002
31. Hu C, Pang S, Kong X, Velleca M, Lawrence JC Jr: Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc Natl Acad Sci U S A 91: 3730-3734, 1994
32. Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, Lawrence JC Jr: PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266: 653-656, 1994
33. Fadden P, Haystead TA, Lawrence JC Jr: Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J Biol Chem 272: 10240-10247, 1997
34. Wettstein FO, Staehelin T, Noll H: Ribosomal aggregate engaged in protein synthesis: Characterization of the ergosome. Nature 197: 430-435, 1963
35. Blazar BR, Taylor PA, Snover DC, Sehgal SN, Vallera DA: Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. J Immunol 151: 5726-5741, 1993
36. Chen H, Qi S, Xu D, Wu J, Daloze P: The immunosuppressive effect of rapamycin on mouse small bowel transplantation. Transplantation 61: 523-526, 1996
37. Young J, Povey S: The genetic basis of tuberous sclerosis. Mol Med Today 4: 313-319, 1998
38. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ: Molecular genetic advances in tuberous sclerosis. Hum Genet 107: 97-114, 2000
39. Potter CJ, Pedraza LG, Xu T: Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4: 658-665, 2002
40. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, Edgar BA: Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol 5: 566-571, 2003
41. Proud CG: Role of mTOR signalling in the control of translation initiation and elongation by nutrients. Curr Top Microbiol Immunol 279: 215-244, 2004
42. Hay N, Sonenberg N: Upstream and downstream of mTOR. Genes Dev 18: 1926-1945, 2004
43. Usui I, Haruta T, Iwata M, Takano A, Uno T, Kawahara J, Ueno E, Sasaoka T, Kobayashi M: Retinoblastoma protein phosphorylation via PI 3-kinase and mTOR pathway regulates adipocyte differentiation. Biochem Biophys Res Commun 275: 115-120, 2000
44. Ilyin GP, Glaise D, Gilot D, Baffet G, Guguen-Guillouzo C: Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am J Physiol Gastrointest Liver Physiol 285: G115-G127, 2003
45. Matthews BF: Growth of the maternal kidneys in pregnant mice [Proceedings]. J Physiol 273: 84P, 1977
46. Blommaart EF, Luiken JJ, Blommaart PJ, van Woerkom GM, Meijer AJ: Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J Biol Chem 270: 2320-2326, 1995
47. Huang HC, Preisig PA: G1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth. Kidney Int 58: 162-172, 2000
48. Bell SP, Dutta A: DNA replication in eukaryotic cells. Annu Rev Biochem 71: 333-374, 2002
49. Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278: F515-F529, 2000
50. Wolf G, Wenzel UO: Angiotensin II and cell cycle regulation. Hypertension 43: 693-698, 2004